Anika Therapeutics Inc (ANIK)

Cash & Equivalents

$38.41M

Quarterly · Period ending: · USD

ANIK logo

ANIK Cash & Equivalents

Latest reported$38.41M
ANIK Quarterly Cash & Equivalents ($5.40M → $38.41M)
High-resolution chart · PNG

ANIK cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Anika Therapeutics Inc Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
8,263,944
6,386,749
8,265,936
5,678,470
5,469,430
8,946,312
6,400,000
1,400,000
5,200,000
5,600,000
10,700,000
12,700,000
23,500,000
22,400,000
22,700,000
3,100,000
2,900,000
2,600,000
2,900,000
3,700,000
4,000,000
1,500,000
2,200,000
2,800,000
3,300,000
1,600,000
2,000,000
2,600,000
3,300,000
3,500,000
4,500,000
5,100,000
5,400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.